GO:0006303 double-strand break repair via nonhomologous end joining: DNA Repair Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006303 describes the repair of DNA double-strand breaks by direct rejoining of broken ends with little or no sequence complementarity, a process also known as nonhomologous end joining (NHEJ).
• NHEJ encompasses both classical/canonical (C-NHEJ) and alternative (A-NHEJ) pathways, and the molecular details of sub-pathways remain an active area of investigation.
• Core C-NHEJ factors include the Ku70/Ku80 heterodimer, DNA-PKcs, XRCC4, LIG4, XLF, and APLF, which together recognize, process, and ligate broken DNA ends.
• NHEJ is essential for V(D)J recombination, class switch recombination, and maintenance of genome stability, and its dysfunction is linked to immunodeficiency, cancer predisposition, and radiosensitivity.
• CRISPR-Cas9-induced double-strand breaks are predominantly repaired by NHEJ, making this pathway central to knockout generation and to understanding editing outcomes.
• Experimental dissection of NHEJ uses knockout, point-mutation, knock-in, and overexpression cell models combined with sequencing, imaging, and biochemical assays.
Description
Double-strand breaks (DSBs) are among the most cytotoxic DNA lesions, and their misrepair can drive genomic instability. GO:0006303, double-strand break repair via nonhomologous end joining, describes the process by which broken DNA ends are rejoined with little or no sequence complementarity, often with loss of information at the break site. This term covers both classical (C-NHEJ) and alternative (A-NHEJ) pathways, which may further branch into sub-pathways whose evidence remains incomplete. Understanding NHEJ is fundamental for researchers in genome stability, immunology, cancer biology, and gene editing, because NHEJ is the dominant repair route for programmed DSBs such as those generated during V(D)J recombination and by CRISPR-Cas9. The pathway is also a major determinant of editing outcomes, including small insertions and deletions that can disrupt gene function. This article synthesizes the QuickGO definition and verified literature to provide a research-grade overview of NHEJ mechanisms, key genes, disease links, and experimental models.
double-strand break repair via nonhomologous end joining At A Glance
| GO ID | GO:0006303 |
|---|---|
| GO term | double-strand break repair via nonhomologous end joining |
| Ontology | biological_process |
| Synonym | NHEJ |
| Major function | Rejoining of DNA double-strand breaks with little or no sequence complementarity, encompassing C-NHEJ and A-NHEJ |
| Definition source | QuickGO |
| Related processes | V(D)J recombination, class switch recombination, CRISPR-Cas9 editing outcomes |
| Key factors | Ku70/Ku80, DNA-PKcs, XRCC4, LIG4, XLF, APLF, and others |
What Is GO:0006303?
GO:0006303 is defined as the repair of a double-strand break in DNA in which the two broken ends are rejoined with little or no sequence complementarity. Information at the DNA ends may be lost due to modification of broken DNA ends. The term covers instances of separate pathways, called classical (or canonical) and alternative nonhomologous end joining (C-NHEJ and A-NHEJ). These in turn may further branch into sub-pathways, but evidence is still unclear.
Why Is double-strand break repair via nonhomologous end joining Important in Cell Biology?
NHEJ is the primary repair pathway for DNA double-strand breaks in mammalian cells and is essential for development, immune diversity, and genome maintenance. Its dysfunction causes severe combined immunodeficiency, radiosensitivity, and cancer predisposition, while its activity shapes the outcomes of genome editing. Because NHEJ can rejoin incompatible ends, it is both a guardian of genome integrity and a source of mutagenic repair, making it a central topic in cancer research, immunology, and therapeutic gene editing.
• NHEJ is the dominant DSB repair pathway in mammalian cells and is required for V(D)J recombination and lymphocyte development.
• Defects in NHEJ factors cause immunodeficiency, radiosensitivity, and cancer predisposition syndromes.
• NHEJ determines the outcome of CRISPR-Cas9 editing, including indels and precise knock-in when combined with homology-directed repair or MMEJ.
• Alternative NHEJ (A-NHEJ) contributes to chromosomal translocations and genomic instability in cancer.
• NHEJ is a target for radiosensitization strategies in cancer therapy.
• NHEJ is conserved across species, from bacteria to plants to humans, enabling comparative studies.
• NHEJ is essential for the repair of programmed DSBs in immune receptor diversification.
• NHEJ research informs the design of safer and more efficient genome editing tools.
What Happens During double-strand break repair via nonhomologous end joining?
DSB recognition and end binding by Ku
In simple terms: The cell detects a broken DNA end and puts a ring-like protein clamp on it.
The Ku70/Ku80 heterodimer rapidly binds DNA ends and serves as the initial sensor of the break, recruiting downstream factors. Ku binding protects ends and is a prerequisite for classical NHEJ.
Recruitment of DNA-PKcs and end processing
In simple terms: A large kinase is recruited to the break, and the ends are trimmed if needed.
DNA-PKcs is recruited by Ku and forms the DNA-PK holoenzyme, which coordinates end synapsis and processing. End processing may involve nucleases and polymerases that remove or add nucleotides, leading to loss of sequence information.
Ligation by the XRCC4-LIG4-XLF complex
In simple terms: The broken ends are sealed back together by a dedicated ligase complex.
The XRCC4-LIG4 complex, stimulated by XLF, catalyzes the final ligation step. APLF and other accessory factors modulate the efficiency and fidelity of this step.
Alternative NHEJ (A-NHEJ) and microhomology-mediated end joining
In simple terms: A backup pathway uses short matching sequences to join ends when classical NHEJ is unavailable.
A-NHEJ is a Ku-independent pathway that often uses microhomology and is associated with chromosomal translocations. MMEJ is a related mechanism that can be exploited for CRISPR-Cas9-mediated knock-in using PITCh systems.
RNA-mediated end joining
In simple terms: RNA molecules can also help join broken DNA ends in some contexts.
Recent evidence indicates that RNA can mediate DSB repair by end-joining mechanisms, expanding the known repertoire of NHEJ-related processes.
Key Genes Involved in GO:0006303 double-strand break repair via nonhomologous end joining
The following genes and proteins are central to NHEJ and are commonly studied using CRISPR-based models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| XRCC6 (Ku70) | Binds DNA ends as a heterodimer with Ku80 | Core C-NHEJ factor; knockout causes radiosensitivity and DSB repair defects |
| XRCC5 (Ku80) | Forms Ku heterodimer with Ku70 | Essential for Ku-mediated end recognition |
| PRKDC (DNA-PKcs) | Kinase recruited by Ku; coordinates end synapsis | Key regulator of C-NHEJ; mutations cause immunodeficiency |
| XRCC4 | Scaffold for LIG4 | Required for ligation step |
| LIG4 | DNA ligase IV | Catalyzes final ligation; mutations cause LIG4 syndrome |
| NHEJ1 (XLF) | Stimulates LIG4 activity | Defects cause immunodeficiency and radiosensitivity |
| APLF | Accessory factor in NHEJ | Modulates end processing and ligation |
| POLM (Pol mu) | Polymerase that fills gaps during NHEJ | Contributes to junction diversity |
| POLX (Pol lambda) | Polymerase involved in NHEJ | Participates in end processing |
| DCLRE1C (Artemis) | Nuclease that processes hairpin ends | Required for V(D)J recombination; mutations cause SCID |
| TP53BP1 | Recruits NHEJ factors to DSBs | Promotes NHEJ over HR; knockout shifts repair to HR |
| MRE11 | Part of MRN complex; involved in end resection | Resection antagonizes NHEJ and promotes HR |
| RAD50 | Part of MRN complex | Coordinates DSB sensing and repair choice |
| NBN (Nibrin) | Part of MRN complex | Mutations cause Nijmegen breakage syndrome |
| ATM | Kinase that activates DSB response | Regulates repair pathway choice |
| BRCA1 | Promotes homologous recombination | Antagonizes NHEJ; mutations cause breast/ovarian cancer |
| 53BP1 | Promotes NHEJ | Key factor in repair pathway choice |
| CTIP (RBBP8) | Promotes end resection | Antagonizes NHEJ |
How Is double-strand break repair via nonhomologous end joining Regulated?
NHEJ is regulated by cell cycle stage, with C-NHEJ active throughout the cell cycle while homologous recombination is restricted to S/G2 phases. The choice between NHEJ and HR is controlled by antagonistic factors such as 53BP1 and BRCA1, which compete for DSB ends. ATM signaling and the MRN complex (MRE11-RAD50-NBN) coordinate the initial response and influence pathway choice. Post-translational modifications, including phosphorylation by DNA-PKcs and ATM, modulate the assembly and activity of NHEJ factors. Additionally, RNA-mediated end joining has been described as a regulatory layer in some contexts.
double-strand break repair via nonhomologous end joining and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DCLRE1C (Artemis) | Severe combined immunodeficiency (SCID) | Knockout cell line and patient-derived iPSCs |
| LIG4 | LIG4 syndrome (immunodeficiency, radiosensitivity) | Point-mutation knock-in in HEK293 or HCT116 |
| NHEJ1 (XLF) | Immunodeficiency with radiosensitivity | Knockout and complementation models |
| TP53BP1 | Cancer predisposition and repair pathway choice | Knockout and overexpression cell lines |
| BRCA1 | Breast and ovarian cancer | Knockout and point-mutation models |
Immunodeficiency and V(D)J recombination defects
NHEJ is essential for V(D)J recombination, and mutations in NHEJ factors such as DCLRE1C (Artemis), LIG4, and NHEJ1 cause severe combined immunodeficiency (SCID) and radiosensitivity syndromes. These disorders highlight the non-redundant role of NHEJ in lymphocyte development.
Cancer predisposition and genomic instability
Defects in NHEJ lead to chromosomal instability and increased cancer risk, while alternative NHEJ can generate oncogenic translocations. Tumors with NHEJ deficiencies may show sensitivity to DNA-damaging agents, offering therapeutic opportunities.
Neurodegeneration and aging
Persistent DSBs and defective NHEJ contribute to neuronal loss and aging-related pathologies, as post-mitotic neurons rely heavily on NHEJ for DSB repair. However, direct evidence linking specific NHEJ mutations to neurodegeneration is still emerging.
From double-strand break repair via nonhomologous end joining-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate NHEJ gene impair DSB repair? | Knockout cell line (e.g., HEK293, U2OS) |
| Does a specific mutation affect NHEJ activity? | Point-mutation knock-in via CRISPR |
| Can a repair factor be visualized at DSBs? | Tagged knock-in (e.g., GFP) |
| Does overexpression of a factor enhance NHEJ? | Overexpression cell line |
| Which NHEJ sub-pathway is used at a given break? | Reporter-based knock-in assays |
| How does NHEJ deficiency affect CRISPR editing outcomes? | Knockout of NHEJ genes followed by CRISPR-Cas9 targeting |
How to Study the double-strand break repair via nonhomologous end joining Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR-Cas9 indel sequencing | NHEJ-mediated insertions/deletions | Assessing editing outcomes |
| Reporter-based NHEJ assay | End-joining activity | Screening for NHEJ modulators |
| Immunofluorescence | Recruitment of NHEJ factors to DSBs | Validating factor localization |
| In vitro ligation assay | Biochemical ligation activity | Mechanistic studies |
| Comet assay | DSB repair kinetics | Measuring repair capacity |
| PITCh knock-in | MMEJ-mediated gene knock-in | Precise genome editing |
| RNA-seq | Transcriptional changes after DSB induction | Pathway analysis |
| Proteomics | Protein interactions at DSBs | Identifying novel NHEJ factors |
CRISPR-Cas9 editing and indel analysis
CRISPR-Cas9 generates DSBs that are predominantly repaired by NHEJ, producing indels that can be quantified by sequencing to assess NHEJ efficiency.
Reporter assays for NHEJ
Fluorescent or luminescent reporters that are reconstituted upon end joining allow quantitative measurement of NHEJ activity in live cells.
Imaging of DSB repair foci
Immunofluorescence for factors such as 53BP1, Ku70, and XRCC4 enables visualization of NHEJ factor recruitment to DSB sites.
Biochemical reconstitution and structural studies
Purified NHEJ proteins can be used in in vitro ligation assays to dissect mechanism and identify inhibitors.
How CRISPR Can Be Used to Study GO:0006303 double-strand break repair via nonhomologous end joining
Knockout
Knockout of core NHEJ genes such as XRCC6, PRKDC, or LIG4 using CRISPR-Cas9 disrupts DSB repair and sensitizes cells to DNA-damaging agents, providing models to study pathway necessity.
Point Mutation
Point mutations in NHEJ genes can be introduced by CRISPR-Cas9 with donor templates to model patient-specific mutations, such as those in LIG4 or DCLRE1C, and to dissect domain functions.
Knock-in
Knock-in of tags or reporters into NHEJ loci enables live-cell imaging and quantitative assays of factor recruitment and dynamics.
Overexpression
Overexpression of NHEJ factors can enhance end joining and may alter repair pathway choice, providing tools to study gain-of-function effects.
How EDITGENE Supports double-strand break repair via nonhomologous end joining Research
Researchers studying double-strand break repair via nonhomologous end joining-related genes often need to determine whether a candidate gene is causally involved in DSB repair, how mutations affect pathway choice, and whether modulating its activity can alter editing outcomes. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to address these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for double-strand break repair via nonhomologous end joining research.
Frequently Asked Questions About double-strand break repair via nonhomologous end joining
What is double-strand break repair via nonhomologous end joining?
It is the process of rejoining broken DNA ends with little or no sequence complementarity, also known as NHEJ, and is defined by GO:0006303.
What genes are involved in nonhomologous end joining?
Key genes include XRCC6 (Ku70), XRCC5 (Ku80), PRKDC (DNA-PKcs), XRCC4, LIG4, NHEJ1 (XLF), APLF, DCLRE1C (Artemis), and TP53BP1.
What is the difference between C-NHEJ and A-NHEJ?
C-NHEJ is the classical Ku-dependent pathway, while A-NHEJ is a backup, often Ku-independent pathway that uses microhomology and is associated with translocations.
How does NHEJ affect CRISPR-Cas9 editing?
CRISPR-Cas9-induced DSBs are predominantly repaired by NHEJ, leading to indels that can disrupt gene function, and NHEJ efficiency influences editing outcomes.
What diseases are linked to NHEJ defects?
NHEJ defects cause immunodeficiency, radiosensitivity syndromes, and cancer predisposition, such as LIG4 syndrome and Artemis-deficient SCID.
How can I study NHEJ in the lab?
Common methods include CRISPR knockout of NHEJ genes, reporter assays, immunofluorescence for repair foci, and in vitro ligation assays.
What is the role of Ku70/Ku80 in NHEJ?
Ku70/Ku80 forms a heterodimer that binds DNA ends and recruits downstream factors, initiating classical NHEJ.
Can NHEJ be targeted for cancer therapy?
Inhibitors of NHEJ factors such as DNA-PKcs are being explored as radiosensitizers, and NHEJ-deficient tumors may respond to DNA-damaging agents.
What is microhomology-mediated end joining?
MMEJ is a related end-joining pathway that uses short microhomologies and can be exploited for CRISPR knock-in using PITCh systems.
How does EDITGENE support NHEJ research?
EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services for NHEJ studies.
Conclusion
GO:0006303 double-strand break repair via nonhomologous end joining is a fundamental biological process that safeguards genome integrity and shapes immune diversity and genome editing outcomes. Its dual role in protecting and mutating the genome makes it a critical area of research in cancer, immunology, and gene therapy. By leveraging CRISPR-based cell models and advanced screening, researchers can dissect NHEJ mechanisms and translate findings into therapeutic strategies.
References
- 1. Chang HHY et al.. 2017. Non-homologous DNA end joining and alternative pathways to double-strand break repair.. Nat Rev Mol Cell Biol 18(8):495-506 PMID: 28512351
- 2. Jeon Y et al.. 2024. RNA-mediated double-strand break repair by end-joining mechanisms.. Nat Commun 15(1):7935 PMID: 39261460
- 3. Cejka P et al.. 2021. DNA End Resection: Mechanism and Control.. Annu Rev Genet 55:285-307 PMID: 34813349
- 4. Stinson BM et al.. 2021. Repair of DNA Double-Strand Breaks by the Nonhomologous End Joining Pathway.. Annu Rev Biochem 90:137-164 PMID: 33556282
- 5. Sakuma T et al.. 2016. MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems.. Nat Protoc 11(1):118-33 PMID: 26678082
- 6. Richardson CD et al.. 2016. Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA.. Nat Biotechnol 34(3):339-44 PMID: 26789497
- 7. Shen H et al.. 2017. CRISPR/Cas9-Induced Double-Strand Break Repair in Arabidopsis Nonhomologous End-Joining Mutants.. G3 (Bethesda) 7(1):193-202 PMID: 27866150
